POZEN Logo
Print Page   Close Window

Press Release

POZEN to Present on Panel at the BIO CEO & Investor Conference

CHAPEL HILL, N.C., Feb 09, 2006 (BUSINESS WIRE) -- POZEN Inc. (NASDAQ: POZN) announced today that John R. Plachetka, Pharm.D., the company's chairman, president and chief executive officer, will present as part of a panel entitled, "Cure the Pain," at the BIO CEO & Investor Conference on Tuesday, February 14, 2006 at 4:00 p.m., ET, in the Basildon Room at The Waldorf-Astoria, New York, NY.

The panel presentation will be available via webcast beginning February 15, 2006 and can be viewed on the BIO website at: http://ceo.bio.org/opencms/ceo/2006/index.jsp

POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. Since its inception, POZEN has focused its efforts primarily on the development of pharmaceutical products for the treatment of acute and chronic pain, migraine, and other pain-related conditions. POZEN has a development and commercialization alliance with GlaxoSmithKline. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.

SOURCE: POZEN Inc.

POZEN Inc.
Bill Hodges, 919-913-1030
Chief Financial Officer
or
Fran Barsky, 919-913-1044
Director, Investor Relations